Sign in
Taking people in United StatesPhase 4

Dexamethasone before thyroid surgery in Graves disease and Hashimoto disease

Tests dexamethasone before surgery in adults with Graves disease or Hashimoto disease.

Key facts

Who runs it
Indiana University
Where
Indianapolis, United StatesSee the 3 sites
Trial code
Registry title
Preoperative Corticosteroids in Autoimmune Thyroid Disease
Status
Recruiting
Phase
Phase 4
People taking part
76 people, planned
Started
16 Jun 2023
Expected to end
30 Jun 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Dexamethasone
  • Placebo
Record updated
5 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with Graves' disease or Hashimoto's disease who are about to have their whole thyroid removed. It tests whether a short course of corticosteroids before surgery reduces gland inflammation.

Age
18 years and older.
Sex
All sexes can join.
Disease stage
Graves' disease or Hashimoto's disease (autoimmune thyroid disease), with total thyroidectomy (removal of the whole thyroid) planned.
Earlier treatment
People who had RAI (radioactive iodine) treatment or earlier neck surgery cannot join. People with recent steroid therapy cannot join.
Biomarker or test result
Positive thyroid autoantibodies (TgAb, TPO, TSI, and/or TRAb).

Main reasons for not taking part

  • Known thyroid cancer
  • Diabetes treated with medicines
  • Earlier bad reaction to corticosteroids
  • Taking any medicine that weakens the immune system, such as after an organ transplant or for another autoimmune disease
  • Under 18 years old

The registry criteria, word for word

Show all 2 criteriaShow less

Other criteria

  • Inclusion Criteria:; ■ Graves' disease or Hashimoto's disease with positive thyroid autoantibodies (TgAb, TPO, TSI, and/or TRAb) undergoing total thyroidectomy for their disease
  • Exclusion Criteria:; Pediatric patients < 18; Prior treatment with RAI; Prior neck surgeries; Known diagnosis of thyroid cancer; Diabetic patients on medications; A history of adverse reactions to corticosteroids; Patients on any immunosuppressive regimen (such as organ transplant patients or patients treated for other autoimmune conditions). This includes patients with recent history of steroid therapy, or a history of adverse reactions to corticosteroids

Where in United States

  • IU Health Methodist HospitalIndianapolis, United StatesContact: Robin GardinerTaking people
  • IU Health North HospitalIndianapolis, United StatesContact: Robin GardinerTaking people
  • IU Health University HospitalIndianapolis, United StatesContact: Robin GardinerTaking people

About the trial

What the trial wants to find out

This study proposes to randomize patients about to undergo surgery for their autoimmune, inflammatory thyroid disease, and determine if a short course of corticosteroids decreases the inflammation of the gland and makes surgery less difficult.

The 2 groups in the trial

  • SteroidsTreatment being tested

    Will be given pre-operative corticosteroid regimen

    Treatment: Dexamethasone

  • placeboPlacebo, for comparison

    Will be given Placebo

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Randomized Controlled Trial of Preoperative Corticosteroids in Autoimmune ThyroidDisease
Plain-language title
Dexamethasone before thyroid surgery in Graves disease and Hashimoto diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
5 August 2026